Theramex is listed as a current portfolio company of The Carlyle Group on The Carlyle Group's own portfolio page. The Carlyle Group has owned Theramex since 2022, per The Carlyle Group's portfolio page.
Theramex is a Healthcare company. Its owner on record, The Carlyle Group, is a leveraged buyouts firm founded in 1987, headquartered in Washington, D.C., USA, with $441 billion under management. The Carlyle Group lists 257 companies in the index, 41 of them in Healthcare.
The Carlyle Group is an American multinational private equity, alternative asset management, and financial services firm.
Read the The Carlyle Group profileCinven acquired Theramex
privateequitywire.comTheramex is listed as a current portfolio company of The Carlyle Group on The Carlyle Group's own portfolio page. The Carlyle Group has owned Theramex since 2022, per The Carlyle Group's portfolio page.
Theramex is in Healthcare. Classified from the owner's portfolio label.
The Carlyle Group is headquartered in Washington, D.C., USA.
The Carlyle Group lists 40 other Healthcare companies in the index, including Abacus Pharmaceuticals, Abbisko, Acufocus, Inc., Adicon Holdings Limited and Ambio Holdings, Inc..
6 of 256 shown
See the full The Carlyle Group portfolio.
Browse PE-backed companies.
